Search research articles
Contact Us
Filters
Showing results (171-180 of 357) with videos related to
Page
of 36
Sort By:
Circulation
|
July 1, 1973
Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients
A G Bartel, V S Behar, R H Peter, et al.
Mentoring & Tutoring
|
September 28, 2020
Assessing Mentor Academy Program Effectiveness using Mixed Methods
Linda S Behar-Horenstein, Xiaoying Feng, Alena Prikhidko, et al.
Circulation
|
August 3, 1999
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry
M Haim, M Benderly, D Brunner, et al.
Journal of the American College of Cardiology
|
June 11, 1999
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease
J Leor, H Reicher-Reiss, U Goldbourt, et al.
Circulation
|
April 1, 1978
Relationships among ventricular arrhythmias, coronary artery disease, and angiographic and electrocardiographic indicators of myocardial fibrosis
R M Califf, J M Burks, V S Behar, et al.
Circulation
|
October 1, 1980
Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death
P J Harris, K L Lee, F E Harrell, et al.
European Heart Journal
|
January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study Group
S Behar, E Graff, H Reicher-Reiss, et al.
Circulation
|
November 1, 1976
Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation
B W Gilbert, R A Schatz, O T VonRamm, et al.
Circulation
|
September 1, 1976
Analysis of secondary pauses following termination of rapid atrial pacing in man
D G Benditt, H C Strauss, M M Scheinman, et al.
The American Journal of Cardiology
|
June 15, 1996
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group
M Jonas, H Reicher-Reiss, V Boyko, et al.
Page
of 36
Search research articles
Search
Showing results (171-180 of 357) with videos related to
Sort By:
Page
of 36
Circulation
|
July 1, 1973
Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients
A G Bartel, V S Behar, R H Peter, et al.
Mentoring & Tutoring
|
September 28, 2020
Assessing Mentor Academy Program Effectiveness using Mixed Methods
Linda S Behar-Horenstein, Xiaoying Feng, Alena Prikhidko, et al.
Circulation
|
August 3, 1999
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry
M Haim, M Benderly, D Brunner, et al.
Journal of the American College of Cardiology
|
June 11, 1999
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease
J Leor, H Reicher-Reiss, U Goldbourt, et al.
Circulation
|
April 1, 1978
Relationships among ventricular arrhythmias, coronary artery disease, and angiographic and electrocardiographic indicators of myocardial fibrosis
R M Califf, J M Burks, V S Behar, et al.
Circulation
|
October 1, 1980
Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death
P J Harris, K L Lee, F E Harrell, et al.
European Heart Journal
|
January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study Group
S Behar, E Graff, H Reicher-Reiss, et al.
Circulation
|
November 1, 1976
Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation
B W Gilbert, R A Schatz, O T VonRamm, et al.
Circulation
|
September 1, 1976
Analysis of secondary pauses following termination of rapid atrial pacing in man
D G Benditt, H C Strauss, M M Scheinman, et al.
The American Journal of Cardiology
|
June 15, 1996
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group
M Jonas, H Reicher-Reiss, V Boyko, et al.
Page
of 36